Plain-English translation of NCT06280443 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is looking at sarcopenia โ a condition where people lose muscle mass and strength โ in patients who have chronic lung diseases such as COPD, asthma, or interstitial lung disease. Researchers want to understand how often this happens and how it affects people's daily lives and health care needs. The study will use simple strength tests, walking tests, and body composition scans to identify who has muscle loss and how severe it is.
Many people with chronic lung diseases struggle not just with their lungs, but also with losing muscle and becoming weaker. This trial exists to understand how common muscle loss is in this group and what it means for their overall health and ability to function day-to-day.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the hospital for testing sessions where researchers will measure your grip strength, ask you to stand up and sit down repeatedly, watch how fast you walk, and have you walk as far as you can in six minutes. You'll also have two body composition scans โ one using electrical currents and one using X-rays โ to measure your muscle and bone mass. The study is observational, meaning researchers are watching and measuring rather than giving you a treatment; they'll follow your health over time using your medical records.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
Taiwan
Sponsor
Taichung Veterans General Hospital
Enrollment target
~300 participants
Started
November 2022
Primary completion
October 2024
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
20 Years and older
Last updated on clinicaltrials.gov in April 2024.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Pin-Kuei Fu
Taichung Veterans General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.